Alzheimer's disease & dementia

Investigating plasma levels as a biomarker for Alzheimer's disease

A Centre for Healthy Brain Ageing (CHeBA) paper published in Current Alzheimer Research presents the first detailed study of the relationship between plasma levels of two amyloid beta peptides (Aβ1-40 and Aβ1-42), brain ...

page 6 from 7